Elanco Animal Health Incorporated (ELAN) — closed signal from August 27, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on November 25, 2025.
Predicted vs. what happened
What happened
Reached its target in 89 days.
The thesis — published August 27, 2025
Elanco may get a short boost as it joins the S&P MidCap 400 on 2025-09-02. When a stock enters an index, funds that track it often must buy, which can lift prices, but pullbacks after the change are common. Buying near $18.25-$18.80 aims to catch late demand, but the business looks weak, so keep risk tight and react fast. We will watch trading before and after the event.
Primary drivers
- Index addition set; S&P MidCap 400 entry effective on 2025-09-02.
- Near-term automatic buying from index-tracking funds may lift demand.
- Recent price strength suggests buyers are in control for now, but can fade.
- Company fundamentals look weak, so gains may not last after the event.
How it played out
ELAN: target reached in 89 days
Lyra published ELAN at $18.68 on 2025-08-27, with an entry zone of $18.25 to $18.80 and expected growth of 24%. The thesis pointed to Elanco joining the S&P MidCap 400 on 2025-09-02, possible buying from index-tracking funds, recent price strength, and the risk that gains could fade because the business looked weak.
Inside the window, ELAN reached the $23.17 target. Its peak was $23.59 on 2025-11-25, with a peak gain of 26.3%. The target was reached in 89 days. The stock ended at $23.43. The thesis played out on price.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.